Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Adiposity / Obesity is becoming increasingly common among Inflammatory Bowel Disease (IBD) patients, especially in developed countries. Epidemiological studies suggest that 15 to 40% of Inflammatory Bowel Disease (IBD) patients are obese. This high prevalence underscores the importance of understanding the interplay between obesity and Inflammatory Bowel Disease (IBD).
Visceral adiposity, rather than overall body mass, appears to play a crucial role in IBD. The dysfunction of mesenteric fat can exacerbate the inflammatory course of Crohn's disease and may contribute to the formation of strictures or fistulas
Kim et al. 2023c World J Gastroe…